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ABSTRACT
In this work, we examine regulation of DNA
methyltransferase 1 (DNMT1) by the DNA damage
inducible protein, GADD45a. We used a system to
induce homologous recombination (HR) at a unique
double-strand DNA break in a GFP reporter in mam-
malian cells. After HR, the repaired DNA is
hypermethylated in recombinant clones showing
low GFP expression (HR-L expressor class),
while in high expressor recombinants (HR-H clones)
previous methylation patterns are erased. GADD45a,
which is transiently induced by double-strand
breaks, binds to chromatin undergoing HR repair.
Ectopic overexpression ofGADD45aduring repair in-
creases the HR-H fraction of cells (hypomethylated
repaired DNA), without altering the recombination
frequency. Conversely, silencing of GADD45a in-
creases methylation of the recombined segment
and amplifies the HR-L expressor (hypermethylated)
population. GADD45a specifically interacts with
the catalytic site of DNMT1 and inhibits methylation
activity in vitro. We propose that double-strand DNA
damage and the resulting HR process involves
precise, strand selected DNA methylation by
DNMT1 that is regulated by GADD45a. Since
GADD45a binds with high avidity to hemimethylated
DNA intermediates, it may also provide a barrier to
spreading of methylation during or after HR repair.
INTRODUCTION
In mammals, methylation is directed primarily at the
cytosine residues of CpG dinucleotides. DNA methylation
induces transcriptional repression by preventing binding
of basal transcription machinery or other transcription
factors that require contact with cytosine residues
(1). There are two types of DNA methylation, stable
and metastable. Stable methylation is inherited through
generations in a male- or female-speciﬁc fashion. In
contrast, metastable methylation is variable and generates
different methylation patterns among individual cells and
cell types. It is modiﬁed by environment and changes
during the lifetime of individual somatic cells. Defective
metastable methylation is inherently dangerous and can
lead to loss of somatic cell growth regulation and
cellular transformation. The root cause of inappropriate
methylation is not understood, although it may be related
to DNA damage pathways (2–4).
DNA is continually being exposed to cellular metabol-
ites and exogenous DNA-damaging agents, leading to cell
death and/or changes in gene expression, which attend loss
of growth control. Of the various forms of DNA damage,
the most dangerous are DNA double-strand breaks
(DSBs), which may create serious problems arising from
inappropriate recombination such as chromosomal trans-
locations (5–8). To deal with the threats posed by DSBs,
cells have developed multiple mechanisms to detect, signal
and repair the regions. Two main pathways, homologous
recombination (HR) and non-homologous end-joining
(NHEJ), are involved in the repair of DSBs (6). In pro-
karyotes, HR has been known to be a major pathway for
the repair of DSBs, while in eukaryotes, NHEJ was
thought to be preferred. More recently, HR has also
been shown to be a major pathway in mammals. These
pathways are largely distinct from one another and
function in complementary ways (9–11). NHEJ involves
the ligation of two DNA ends without homology and is
highly error prone while HR is essentially error free.
In this process, often called gene conversion, a donor
DNA sequence with homology to both sides of the DSB
supplies genetic information to repair the DSB (12,13).
The homologous sequence is copied into the broken
locus, making the repaired locus an exact copy of donor
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ously examined the epigenetic status of DNA repaired
by HR and gene conversion to determine whether the
repaired DNA region was silenced by DNA methylation
(3). This work demonstrated that repaired sites were
subject to methylation by DNMT1, which directs methy-
lation to one strand primarily 30 of the double strand
(DS) break. This leaves open the question of how
DNMT1 action might be directed to act as a de novo
methylase yielding a hemimethylated DNA product that
does not convert to full methylation (see model,
Supplementary Figure S2).
In order to identify DNMT1 regulatory partners in HR,
we evaluated DNA damage inducible factors that have
also been implicated in methylation events. One of these
is the GADD45a (growth arrest and DNA
damage-inducible 45 alpha), which is a small, 18.4kDa
acidic protein originally isolated from cells treated with
UV irradiation (14). Subsequently, it was found to be
induced by a variety of DNA-damage agents, including
ionizing radiation (IR), methyl methansulfonate (MMS)
and medium depletion (15,16). Three GADD45-like
proteins, GADD45a (GADD45), GADD45b (MyD118)
and GADD45g (CR6), have been identiﬁed, sharing
55–60% sequence identity (17). All three genes are indu-
cible by cellular stress, but their expression proﬁle is
distinct in various tissues (18). GADD45a (G45a) has a
strong p53-binding site in the third intron (19). Its induc-
tion by IR is dependent on p53, but the induction by UV,
MMS and medium starvation is not (19,20). G45a is also
regulated by BRCA1 in a p53 dependent manner (21,22),
which suggests a role in HR. The GADD45 family of
proteins interact with multiple intracellular proteins
including proliferating cell nuclear antigen (PCNA),
p21 protein, Cdc2-cyclinB1 complex, core histones and
MTK1/MEKK4 in a JNK pathway (18,23–26). These
various interactions suggest that the GADD45 pathway
has multiple and important roles in signaling of DNA
damage in both p53 dependent and independent modes
(27). Some of these roles are common to all three
isoforms while others may appear to be isoform speciﬁc.
A known role for G45a is in growth arrest following
genotoxic stress. GADD45 proteins bind Cdc2, displace
cyclinB1 from Cdc2 and induce cell cycle arrest (21,28).
In addition, the suppression of GADD45a or GADD45g
by siRNA abrogates growth arrest supporting the import-
ance of their up-regulation after cellular stress (29).
Another biological role of G45a is in DNA repair.
Speciﬁcally, G45a-like DNMT1 interacts with PCNA
and may play a role in nucleotide excision repair (NER)
(23). Antisense RNA experiments revealed that depleting
G45a levels sensitize cells to UV or cisplatin (30) and
G45a null mice exhibit genomic instability and are
highly susceptible to carcinogenesis induced by IR or
UV (26,31). In addition, it has been reported that G45a
interacts directly with core histones to destabilize
histone-DNA complexes following UV irradiation (25).
These ﬁndings imply that G45a binds damaged DNA
in a chromatin setting.
A possible role of G45a in DNA demethylation has
been reported (32) that G45a promotes DNA
demethylation and erases epigenetic marks. G45a
over-expression activated a methylation silenced reporter
plasmid and interacts with repair endonuclease XPG to
direct DNA demethylation suggesting a potential role in
active demethylation; however, this ﬁnding was challenged
by others (33). Recent ﬁndings implicate G45a in active
demethylation associated with base excision repair
(34) and in plants, genomic methylation patterns can be
changed through active demethylation involving a family
of methyl-cytosine glycosylases (35–37).
Here we investigate the role of G45a in DNA methyla-
tion and HR repair. We report that G45a interacts with
the conserved catalytic domain of DNMT1 and inhibits
methylation. Since G45a is transiently induced during
HR, binds HR chromatin and negatively regulates
methylases, we hypothesize that it may inhibit DNA
methylation of one strand of HR repaired DNA. Using
an HR GFP recombination system as a reporter (38), we
found that G45a increases the expression of repaired
DNA suggesting that G45a provides the choreography
associated with strand speciﬁc methylation.
MATERIALS AND METHODS
Plasmids
The cDNAs encoding human GADD45a (G45a) from
HeLa cells were cloned into a pCMV-MYC1 (39) vector.
Expression vectors for V5 epitope tagged full length
DNMT1 and deletion mutants (1–419, 412–1113 and
1114–1616 mutants) have been described (39). DNMT1
deletion mutants and intein fused G45a for GST
pull-down experiments were generated by PCR using
DNMT1-V5 and pCMV-MYC1-G45a as templates,
respectively. DNMT1 deletion mutants were cloned into
pGEX-5X-1 (GE Healthcare Life Sciences) and G45a was
cloned into pTXB1 (NEB). To clone a V5-G45a,
pCMV-nV5-His6 plasmid was constructed by inserting a
V5-His6 linker into pcDNA3.1(+) (Invitrogen) using
HindIII and BamHI sites. G45a PCR products were
cloned into pCMV-nV5-His6 using EcoRV and XbaI
sites. Using Myc-G45a or V5-G45a as a template, point
mutants of G45a, RT34AA, LC56AA, ED63AA and
CE83AA, were generated by PCR using site-directed mu-
tagenesis kit (Stratagene). Primers used in this study are
listed in Supplementary Table S1.
Cell culture and transfection
HeLa-DR-GFP cells, containing a single integrated copy
of the HR reporter (also known as HO-1 cells) (3) were
maintained in RPMI 1640 supplemented with 10% fetal
bovine serum (Gibco). In some experiments (where
indicated), the HeLa DR-GFP cells were analyzed as a
pool of DR-GFP cells and were an uncloned population
representing all integration events. In other experiments, it
was necessary to use cloned HO-1 cells. Both cell systems
gave concordant results. HEK293FT cells (Invitrogen)
were grown in DMEM with 10% fetal bovine serum.
Transfection of plasmids was performed using
Lipofectamine 2000 (Invitrogen) according to manufac-
turer’s instructions. Transfection efﬁciency was measured
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pSVbGal vector (Promega).
Viral production and infection
Lentiviral vectors (shRNA#49 and shRNA#50) for G45a
were purchased from Open Biosystems (clone numbers:
TRCN0000062349 and TRCN0000062350). Scramble
shRNA lentiviral vector for use as a negative control was
obtained from Addgene. We transfected HEK293FT cells
cultured on 6-cm dishes with the shRNA lentiviral vectors
(2mg) together with the packaging plasmids psPAX2
(1.5mg) and pMD2G (0.5mg) using Lipofectamine 2000
reagents. Viral supernatants were harvested on three con-
secutive days starting 24h after transfection, yielding a
total of  15ml of supernatant per virus. HeLa-DRGFP
cells were infected with 150 400ml of viral supernatant
at a density of 200000 cells/well (in 6-well plates) in the
presence of polybrene (9mg/ml).
Co-immunoprecipitations
Whole-cell extracts were prepared by lysing cells in RIPA
buffer (1  PBS pH 7.5, 1% NP-40, 0.5% deoxycholate,
0.1% SDS, 10% glycerol) containing 1  protease inhibi-
tor cocktail (Roche), 1mM DTT, 1mM MgCl2 and 2mM
PMSF. For co-immunoprecipitation, the whole-cell
extracts were diluted four times with 0.5  PBS containing
1  protease inhibitor cocktail, 1mM DTT, 1mM EDTA
and 2mM PMSF. Antibody (1mg) was added to samples
for 3h, followed by 30ml of protein A Sepharose 4B beads
(Zymed) at 4 C for 18h. Beads were washed three times
with 1  PBS, 0.5% NP-40 and bound proteins eluted with
sample buffer (60mM Tris/HCl pH 6.8, 2% SDS, 10%
glycerol, 5% b-mercaptoethanol, 0.01% bromophenol
blue) and analyzed by western blotting. The antibodies
and their commercial sources were as follows: anti-V5
(Invitrogen), anti-DNMT1 (NEB), anti-Flag (Sigma)
and anti-Myc (Upstate).
GST pull downs
Escherichia coli strain BL21 (DE3) was transformed with
plasmid harboring GST fused DNMT1 deletion mutant or
intein fused G45a. Proteins were induced by adding IPTG
to ﬁnal concentration of 0.4mM for 4h at 37 C. Intein
fused G45a was puriﬁed according to manufacturer’s in-
structions (NEB). To purify GST fused DNMT1 deletion
mutants, cell pellets were resuspended in PBS containing
protease inhibitor cocktail (Roche), 1mM PMSF, 10%
glycerol and lysozyme (Sigma, 100mg/ml) and incubated
for 20min on ice. Cells were sonicated and lysates cleared
by centrifugation. Proteins were puriﬁed using
GST-Sepharose 4B (GE Healthcare Life Sciences). To de-
termine the puriﬁcation yield of each deletion mutant,
small aliquots of each bead preparation were mixed with
sample buffer and analyzed by SDS–PAGE. Equal
amounts of each deletion mutants were mixed with
100ng of puriﬁed G45a and incubated overnight. Beads
were extensively washed and bound proteins were
eluted using sample buffer. The eluted proteins were
analyzed by western blot using anti-G45a antibody
(Santa Cruz, C-4).
Chromatin immunoprecipitation
Cells were transfected with either empty vector or I-SceI
plasmid (5mg) along with V5-GADD45a (1.25mg) in
150-mm dishes. After 48h, cells were ﬁxed with 1% for-
maldehyde. Chip-IT Express kit (Active Motif) was used
for chromatin immunoprecipitation (ChIP) experiments.
ChIP reactions were set up according to the manufactur-
er’s instructions. Brieﬂy, the sheared chromatin (corres-
ponding to 18mg of DNA) was mixed with protein G
magnetic beads and 2mg of each antibody or normal
mouse IgG (Santa Cruz). Antibodies used are: anti-V5
(Invitrogen), anti-G45a (H-165, Santa Cruz) and
anti-DNMT1 (N-16, Santa Cruz). The reaction mixtures
were incubated at 4 C for 48h. Beads were washed and
immunoprecipitated DNA was recovered. The enriched
DNAs were analyzed by PCR using Rec and 30-common
primers (see Supplementary Figure S1) (3). PCR was per-
formed in a 20-ml reaction mixture containing 5ml of re-
covered DNA (or 100ng of input DNA), 0.2mM dNTP,
1.25 U of HotStarTaq polymerase (Qaigen) and 5mMo f
each primer. Ampliﬁcations were performed using the fol-
lowing conditions: 95 C/5min 1 cycle; 95 C/45s, 66 C/
40s, and 72 C/40s 40 cycles; and 72 C/10min 1 cycle.
Methylated-dependent immunoprecipitation (MeDIP) and
methyl-sensitive restriction analysis (MSRA)
For MeDIP analysis, HeLa cells were transfected with
4mg of I-SceI expression vector and with 100nM G45a
or EZH2 siRNAs (Dharmacon). Six days later, the
genomic DNA was prepared with QIAamp DNA Mini
Kit (Qiagen) according with the manufacturer instruc-
tions, and 10mg were digested with EcoRI, HindIII and
HpaII (Roche) overnight at 37 C. The digested genomic
DNA was then extracted with phenol-chloroform-isoamyl
alcohol (25:24:1), ethanol precipitated, resuspended in TE
(10mM Tris pH 8.0, 1mM EDTA) and quantiﬁed by
absorbance at 260nm. Next, 2.5mg DNA was diluted in
500ml of IP buffer (0.15% SDS, 1% Triton X-100,
150mM NaCl, 1mM EDTA pH 8.0, 0.5mM EGTA pH
8.0, 10mM Tris pH 8.0, 0.1% BSA, 7mM NaOH) and
incubated at 95 C for 10min before the immunopre-
cipitation with 5mg of 5-methyl cytosine antibody
(Abcam). As a control, 5mg of normal mouse IgG
(Santa Cruz) was included. The samples were incubated
(overnight at 4 C on a rotating platform) followed by
addition of 20ml of Protein A/G Plus-Agarose (Sigma)
and a 2h (4 C). Beads were washed as follows: 2  Low
Salt buffer (0.1% SDS, 0.1% DOC, 1% Triton X-100,
150mM NaCl, 1mM EDTA pH 8.0, 0.5mM EGTA pH
8.0, 10mM Tris pH 8.0); 1  High Salt buffer (0.1% SDS,
0.1% DOC, 1% Triton X-100, 500mM NaCl, 1mM
EDTA, 0.5mM EGTA, 10mM Tris, pH 8.0); 1  LiCl
buffer (0.25M LiCl, 0.5% DOC, 0.5% NP-40, 1mM
EDTA, 0.5mM EGTA, 10mM Tris, pH 8.0); 2  TEE
buffer (1mM EDTA, 0.5mM EGTA, 10mM Tris,
pH 8.0). The immunocomplexes were resuspended in
200ml of Proteinase K solution [50mM Tris, (pH 8.0)
10mM EDTA, 0.5% SDS] and digested with 200mg/ml
Proteinase K (Roche) for 4h at 55 C. The samples were
then extracted with phenol-chloroform-isoamyl alcohol
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8.0 and 1mM EDTA pH 8.0. For the PCR analysis, 2mlo f
immunoprecipitated DNA and 2ml of digested genomic
DNA were used for the PCR reaction. The primers used
are in Supplementary Table S2. In this analysis, two
control genes (H19, an imprinted gene and UBE2B, an
unmethylated DNA control) were included to validate
that methyl-DNA was being selectively precipitated by
the method. PCR was performed in a 20-ml reaction
mixture containing 0.2mM of each primer and 10mlo f
QuantiFast SYBR Green PCR Kit 2  (Qiagen).
Ampliﬁcations were performed using the following condi-
tions: 95 C/15min 1 cycle; 95 C/45s, 65 C/30s, and
72 C/1min 40 cycles; and 72 C/10min 1 cycle for the
Rec2-DRGFP ChIP LOWER R primers. PCR conditions
for H19ICR and UBE2B were: 95 C/10min 1 cycle;
95 C/45s, 59 C/30s, and 72 C/30s 5 cycles; 95 C/45s,
56.5 C/30s and 72 C/30s 35 cycles; 72 C/10min 1
cycle.
For MSRA, genomic DNA was isolated from cells with
DNeasy Blood and Tissue kit (Qiagen). To remove
unrepaired DNA from repaired DNA, total genomic
DNA was digested with I-SceI endonuclease (Fermentas)
prior to bisulﬁte modiﬁcation. The genomic DNA (5mg)
was digested for 18h at 37 C with 10 U of I-SceI enzyme.
The digested DNA was cleaned up using QIAprep Spin
Miniprep kit (Qiagen). To monitor methylation of
repaired sites after HR, 1mg of genomic DNA was
digested with 5U of HpaII before ampliﬁcation with
Rec and 30-common primers. The methylation was
quantiﬁed using a GeneTools software (SynGene,
Cambridge, UK).
In vitro DNA methylation assays
DNA methylation activity assays were performed as
described (39) with slight modiﬁcations. Brieﬂy,
DNMT1 activity was measured in the presence or
absence of puriﬁed GADD45a by the incorporation of
labeled Ado-Met S-adenosyl-L-[methyl-
3H] methionine
(PerkinElmer) into a 30-bp oligonucleotide substrate con-
taining a single CpG site in hemimethylated form
(D1subHMF: 50-GAA GCT GGG ACT TCM GGC
AGG AGA GTG CAA-30, D1subUMF: 50-TTG CAC
TCT CCT GCC GGA AGT CCC AGC TTC-30, where
M denotes 5-methylcytosine) or the same oligo as an
unmethylated substrate. (oligonucleotides from
Integrated DNA Technologies). Double-stranded oligo-
nucleotides were annealed by mixing equal amounts of
complimentary oligonucleotides, heating to 95 C for
5min, 65 C for 10min and cooling down to 20 C.
Under these conditions, reconstruction experiments con-
ﬁrmed that annealing is essentially complete (>99%). The
methylation reaction was carried out at a concentration of
0.5mM DNA, 0.5mCi Ado-Met and 400ng of DNMT1
(puriﬁed from baculovirus) in methylation buffer
(20mM Tris/HCl pH 7.5, 5mM EDTA, 5mM DTT,
1mM PMSF and 10% glycerol) at 37 C. At deﬁned
times, the reactions were stopped by adding phenol/
chloroform and DNA was precipitated by adding the
same volume of isopropyl alcohol. The DNA pellet was
dissolved in TE buffer and transferred to Whatman ﬁlter
paper. Radioactivity was determined using a LS6500 scin-
tillation counter (Beckman Coulter).
Analysis of homologous recombination
Homologous recombination (HR) assays were performed
as previously described (3). HeLa-DRGFP cells or cell
transduced with lentivirus expressing shRNAs were trans-
fected with I-SceI plasmid (sometimes along with
Myc-G45a plasmid) as well as pSVbGal. After transfec-
tion, cells were harvested at deﬁned time points and GFP
positive cells were analyzed by ﬂow cytometry using
FACSCalibur (BD Biosciences). Statistical analyses of
FACS data and expression classiﬁcation (HR-L and
HR-H) was carried out using previously published
methods (see Supplementary Figure S8) (3).
RNA extraction and RT–PCR
Total RNA was isolated from cells with RNeasy Minikit
(Qiagen). cDNA synthesis and ampliﬁcation was
performed with OneStep RT-PCR kit (Qiagen) using
gene speciﬁc primers. Primer sequences are listed in
Supplementary Table S1.
Surface plasmon resonance
DNA–protein interaction analysis was performed
by Surface Plasmon Resonance (SPR) experiments using
a Reichert SR7000 SPR refractometer (Reichert Inc.,
Depew, NY, USA). Two types of binding experiments
were performed. First, duplex biotinylated DNAoligomers
(either unmethylated, hemimethylated or fully methylated
DNA oligomers described above for DNMT1 activity
assays) were immobilized to a neutravidin coated sensor
slide (Reichert Inc., Depew, NY) at a ﬂow rate 6.67ml/
min. Second, puriﬁed His-GADD45a was bound to the
sensor slide (through amide chemistry) at 6.67ml/min
(in this case binding orientation of the protein was
random). Unbound material was washed off with PBS
containing 0.2% Tween-20. HBS buffer (10mM HEPES
pH 7.4, 150mM NaCl and 3mM EDTA) was used as a
running buffer. To determine equilibrium dissociation con-
stants (KD) for DNA–protein interactions, various concen-
trations of either oligo or GADD45awere applied at a ﬂow
rate of 13.3ml/min at 37 C in HBS buffer. Reichert
Labview software was used for data collection. Biologic
Scrubber 2 software (Campbell, Australia) was used
for curve ﬁtting and data analysis. The sensogram raw
data were subjected to curve ﬁtting with regression values
in excess of 97%.
Statistical analyses
Data are presented as the means±SE of at least three
experiments in triplicates (n 9). Statistical signiﬁcance
between groups was determined using Student’s t-test
(matched pairs test or unmatched test were used as
indicated in the ﬁgure legends). Statistical analysis was
performed using the JMP 6.0.3 software by S.A.S (www
.sas.com).
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We previously showed that HR results in methylation
revisions of the post-HR templates using a DR-GFP
reporter (Supplementary Figure S1) (3). These methyla-
tion events localized to a region 30 of the I-SceI cleavage
site, indicated by inverted triangles in Figure 1A.
Following HR repair, hemimethylated intermediates
resolve into two populations of GFP positive cells (corres-
ponding to a high expression class or HR-H, which are
hypomethylated GFP molecules and a low expression
class or HR-L, which are hypermethylated molecules,
see Supplementary Figures S1 and S2). The HR-H and
L populations derive from templating events off the
methylated and unmethylated strands as the cells divide
(3). These two populations were FACS sorted and the
methylation status conﬁrmed by bisulﬁte sequencing
analysis; therefore, we validated that FACS analysis rep-
resents a precise, albeit independent, measurement of
methylation of repaired segments post-HR. We selectively
silenced G45a in HeLa DR-GFP pools of cells (represent-
ing a wide range of integration events) (3) following I-SceI
expression and examined the frequency of recombination
at 5- and 7-day post-HR (Figure 1D). In addition, HR-L
and H expression classes were examined as a readout for
repair induced methylation (Figure 1B and C), and methy-
lation of the 30 GFP segment was directly evaluated over a
437-bp region 30 of the I-SceI site (Figure 1F). The
data show that G45a depletion (Figure 1E) during repair
stimulates formation of hypermethylated recombinant
GFP products (Figure 1B). This was conﬁrmed by
showing an increase in DNA methylation levels at the 30
end of the I-SceI site by methyl-DNA immunopre-
cipitation (Figure 1F). Methyl-DNA immunoprecipitation
(MeDIP) experiments were replicated for statistical
analysis (Supplementary Figure S9). Two external
control genes (H19, imprinted and UBE2B, unmethylated)
were included in the experiment to validate antibody
quality and speciﬁcity. In addition, methyl-C DNA
recovery was unchanged before and after HR at these
two control genes, demonstrating that changes in DNA
methylation selectively target the 30 GFP region after
I-SceI cleavage (data not shown). The PRC2 repressor
component EzH2, responsible for H3K27me3 marks
that silence genes during differentiation (40), was
compared with the G45a results (Figure 1C and E).
Since EzH2 is also recruited to DS DNA breaks (4), we
evaluated the impact of its depletion on post-repair
silencing and recombination frequency. Depletion of
EzH2 alters HR frequency which introduces a bias in
analyzing GFP expression. For this reason, we asked
whether G45a siRNA might similarly affect the frequency
of HR. In contrast to EzH2, HR frequency was not
inﬂuenced by G45a siRNA tested at 5- and 7-day post-I-
SceI. As additional evidence, we show that HR frequency
was not affected by depleting G45 using two different
shRNAs and the DR-GFP reporter cell system (HO-1
cells, containing a single integrated copy of DR-GFP
reporter, Supplementary Figure S7E). The overall trend
is consistent with the view that when G45a is depleted,
greater methylation of GFP molecules is a direct
or indirect result. Using an independent method
(MSRA, methylation sensitive restriction analyses), we
conﬁrmed that two different shRNA G45a knockdowns
in HO-1 cells showed this same trend (enhanced DNMT1
methylation 30 of the I-SceI break) without any change in
HR frequency, as noted (Supplementary Figure S7). The
HO-1 cell system is a more tractable system for analysis of
the kinetics of the HR repair silencing, compared to ex-
periments that use pools of transfected cells (see next
section).
Ectopic G45a relieves HR mediated repression of
recombinants
We next tested the inﬂuence of ectopic high level expres-
sion on total GFP response in the DR-GFP reporter cell
system using a single clonal isolate in HO-1 cells
(2). Increasing amounts of G45a increase total GFP ex-
pression without a detectable change in HR frequency
(Figure 2A). The increase, while not large was highly re-
producible and statistically signiﬁcant (Supplementary
Figure S10); therefore, we conclude that elevated G45a
relieves transcriptional repression due to alterations in epi-
genetic reprogramming. We next tested the kinetics of ex-
pression of the G45a gene after I-SceI transfection of
HO-1 cells (Figure 2B and C). G45a mRNA appears rela-
tively soon after double strand DNA break formation
(4h), peaks between 8 and 12h and is reduced to half by
48h (and continues to decline at later times, not shown).
Similar results were seen in UV treated cells (24h induc-
tion shown in Figure 2B). The ﬁrst detectable GFP
positive cells appear between 24 and 48h (Figure 2B,
Supplementary Figure S4). This time period coincides
with the appearance of G45a protein (Figure 2C). The
peak amount of G45a protein following DSB
(Figure 2C) was slightly delayed relative to the mRNA
(which peaked between 8 and 24h, Figure 2B). Overall,
mRNA and endogenous protein levels increase by  2- to
4-fold after I-SceI exposure. Topoisomerase II induced
DNA breaks due to etoposide treatment showed a
strong induction of G45a protein in untransfected HeLa
cells as expected (greater than UV). These data establish
that G45a induction is early and transient in the reporter
cells. Results with pools of DR-GFP Hela cells (Figure 1)
and a single clone (HO-1 cells) were concordant.
Endogenous G45a and DNMT1 found in recombinant
GFP chromatin
To test the idea that endogenous G45a binds to DNA and/
or DNMT1 and regulates methylation during HR, we
performed chromatin immunoprecipitation (ChIP)
analysis. For this analysis, we transfected cells with I-SceI
and performed a ChIP experiment using speciﬁc and
control antibodies and the Rec primer (Supplementary
Figure S1 map) to amplify recombinant DNA products
speciﬁcally. In the absence of I-SceI, Rec DNA products
were not recovered with any of the antibodies tested
(Figure 3, Lanes 4–7). ChIPs were performed with en-
dogenous G45a and ectopic V5-G45a. The data show
that there is a selective recovery of Rec products with
G45a (endogenous and V5 tag) as well as DNMT1
Nucleic Acids Research,2012, Vol.40, No. 6 2485Figure 1. Silencing of G45a modiﬁes targeted methylation and GFP expression in recombinant cells. (A) Map of the DR-GFP reporter (13). HeLa
cells containing the DR-GFP reporter shown as two cassettes (50 GFP-I and 30 GFP-II) are transfected by an I-SceI expression plasmid. This results
in HR and gene conversion whereby wild-type cassette II serves as donor template to convert the I-SceI site in cassette in GFP-I to a BcgI site. The
inverted triangles in GFP-I of wild-type GFP
+cells mark the 437-bp region of methylation reprogramming that attends this process. A more detailed
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(continued)(3) (Figure 3, Lanes 8–15). The result is highly reproducible
as seen with the DNMT1 ChIP control demonstrating
nearly identical recovery (compare Lanes 11 and 15 and
quantitative data in graph) for both experiments
(comparing endogenous and V5-G45a). Recovery of en-
dogenous G45a was reproducibly lower than that seen
with V5-G45a, which is expected since the V5 promoter
construct is constitutively expressed at higher levels.
G45a and DNMT1 interactions modulate methylase
activity
DNA methylation at HR segments is primarily mediated
by DNMT1 (3) and we considered the possibility that
G45a and DNMT1 might also physically interact
(Figure 4A). G45a binds the C-terminal domain of
DNMT1, the conserved catalytic center of the methylase
(Figure 4C). In a chromatin context, many protein/protein
interactions are likely involved in directing DNMT1 at
HR templates; however, a fundamental question is
whether additional bridging proteins are involved with
G45a. Using GST tagged protein, G45a forms a
complex with the C-terminal catalytic region of DNMT1
(Figure 4B) showing that the two bind directly in vitro.
The result of this interaction was further examined in vitro
by testing the inﬂuence of G45a on DNMT1 methylation
of un- or hemi-methylated oligo targets (Figure 4D). G45a
strongly inhibits DNMT1 activity on both substrates and
the inhibition was clearly affecting the methylation
rate (Figure 4E). Inhibition is partially but not total-
ly overcome by addition of excess hemi-methylated
DNA target; therefore G45a and DNMT1 also compete
for DNA binding (Figure 4E, right panel). It is likely that
G45a has some advantage over DNMT1 in terms of DNA
binding since the KD value for G45a/hemi-methylated
DNA is  0.28mM compared to DNMT1/hemi-
methylated DNA KD of 1.07mM (Supplementary Figure
S6). A binding preference for substrate, combined with
occlusion of the DNMT1 catalytic center could explain
the inhibitory effects of G45a on DNMT1 methylation
(given that G45a also preferentially binds hemimethylated
DNA). Recent protein structure studies on DNMT1
further demonstrate the importance of the catalytic
domain interactions with a central region that makes
close contact with each CpG target at the site of
methylation (41). G45a would interfere with this inter-
action and disrupt the activity of DNMT1 as a result.
Alanine substitutions that alter dimerization potential
affect DNMT1 methylation outcomes
Structural data suggest that G45a proteins function in vivo
as multimers (homodimers or higher oligomers) to induce
cell cycle checkpoints as a stress responder (8,42). Since we
demonstrated that ectopic V5-G45a substitutes for the en-
dogenous activity (Figures 1 and 2), we made alanine
scanning mutations to examine dimerization potential in
cells (Supplementary Figure S3), and tested for three par-
ameters of G45a function in HR silencing (Figure 5):
(i) ability to bind DNMT1; (ii) ability to form
homodimers (or higher multimers) and (iii) inﬂuence on
total GFP expression post-HR. DNMT1/G45a inter-
action data are shown above the histogram in Figure 5.
These data (black boxes, Figure 5 histogram) reveal that
DNMT1 binding correlates generally with its ability to
dimerize, suggesting a multi-protein assembly in chroma-
tin is likely to be strongly dependent on the ability of G45a
to self-associate. Cross tag (V5-G45a, Myc-G45a) pull
down analyses with different alanine substitutions
(Supplementary Figure S5A) show that dimerization was
impaired from 30% to 50% (Figure 5 open boxes, histo-
gram). In addition, total GFP expression (stippled boxes)
was reduced in three of the mutants in proportion to their
ability to dimerize and interact with DNMT1; however,
one mutant (RT34AA) had less impact on GFP expres-
sion possibly due to lower overall expression levels for this
mutant (not shown). A direct comparison between
wild-type G45a and the CE83AA mutant relative to cells
that were inﬂuenced by endogenous G45a alone (no ectop-
ic G45a) indicate that the CE83AA mutant is dominant
negative (Supplementary Figure S5B).
DISCUSSION
A role for G45a in HR silencing
In this work, we used the GFP reporter system, described
by Jasin and co-workers (38), to examine mechanisms that
control DNA methylation of repaired segments. We pre-
viously showed that this process involves DNMT1
mediated methylation of a region that is 30 of the DSB
Figure 1. Continued
map of the process, including the PCR primers used to unambiguously distinguish recombinant (50 Rec) molecules is given in Supplementary Figure
S1. (B and C) Analysis of GFP expression classes. HeLa DR-GFP cells (as a pool of DR-GFP transfected HeLa cells) were transiently transfected
with G45a, EzH2 or scrambled control siRNAs along with the I-SceI expression vector. After 5days the cells were subjected to FACS analysis to
quantify HR-H (H) and HR-L (L) cell populations. The arrows indicate the shift of the cells following the transfection with siRNA. A paired t-test
to compare mean GFP intensity was used; P<0.05 is indicated by the asterisk (n.s., ‘not signiﬁcant’). (D) HR recombination frequency in silenced
cells. Genomic DNA was extracted from HeLa DR-GFP cells (silenced by siRNA G45a or EzH2) at 5- or 7-day post-I-SceI transfection. Speciﬁc
GFP primers (Rec) were used to determine the frequency of HR relative to control cells (I-SceI only) using RT-PCR as described previously (3). The
matched statistical analysis used to derive P-values is shown in Supplementary Figure S9. (E) RNA analysis in G45a and EzH2 silenced cells. The
total RNA was extracted from HeLa DR-GFP cells 48h after the transfection with I-SceI. In all transfections, G45a and EzH2 mRNA levels were
determined by RT-PCR (data normalized to the GAPDH gene). The statistical analysis is presented in Supplementary Figure S8. (F) Methyl-C DNA
content (MeDIP) in G45a silenced cells. Genomic DNA was extracted from HeLa DR-GFP cells 5days after I-SceI transfection, restriction digested
and immunoprecipitated with anti-methyl-C speciﬁc antibodies. The 50 Rec and Unrec primers (Supplementary Figure S1) were used to amplify DNA
recovered from the immunoprecipitate. The data were normalized for the percentage of immunoprecipitated unrecombinant control. Scr is the
scrambled RNA negative control. Mean comparisons were calculated using Student’s t-test (**P=0.0046, G45a and EZH2; P=0.0047, G45a and
Scr control; Scr and EZH2 no signiﬁcant difference, P=0.99) (Supplementary Figure S9). Control experiments with an H19 (a known imprinted
gene) and UBE2B (unmethylated control DNA) were included to demonstrate speciﬁcity of the commercial antibody for methylated DNA; recovery
of immunoprecipitated methyl-C DNA in the control genes was not affected by I-SceI transfection (data not shown).
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methylation status of the 30 wild-type donor GFP
(cassette II) does not direct the ﬁnal epigenetic outcome,
nor do the recombinant clones carry the methylation
pattern of the 50 cassette I. Instead, methylation patterns
are either reprogrammed or overlaid with new patterns
resulting in GFP
+ clones that are either hypo-methylated
or hyper-methylated. Thus, the HR repair product is a
hemi-methylated intermediate (2,3) that resolves into
two GFP expressor populations in daughter cells (hyper
and hypomethylated) (see Supplementary Figure S2). The
intermediate could arise by active demethylation,
mediated by G45a (32,34,43,44), passive (new homologous
strand synthesis) or de novo methylation mechanisms (3)
but results in strand-speciﬁc templating that imprints the
methylation pattern in a permanent fashion. Thus, the
process that transpires during HR repair of the break
becomes a permanent revision to the epigenetic landscape
(Supplementary Figure S2). Previously, we demonstrated
the presence of positive acting factors that act as
co-repressors in HR silencing, such as the DNMT1
binding protein DMAP1 (2). In this article, we ask what
mechanism(s) might prevent or limit re-methylation of the
hemi-methylation intermediate by DNMT1 (an attractive
substrate for the maintenance methylase). We searched for
factors that have been implicated in active epigenetic
reprogramming, that are rapidly induced by DNA
damage and/or genotoxic stress, and might appear early
and transiently in the recombination process (32,43,44).
We ﬁnd that the small DNA damage-inducible protein
G45a ﬁts these criteria. G45a is rapidly induced in
response to genotoxic events such as DSBs induced by
I-SceI damage (14,15,19). Rapid induction and turnover
of the G45a gene is mediated both at the transcriptional
and post-transcriptional levels (45–47) and in non-stressed
(resting) cells, G45a transcripts have a short half-life (47).
The following pieces of evidence suggest a role for G45a as
a negative modulator of DNMT1 targeted methylation
events at sites of double strand break repair by HR.
First, ectopic overexpression of G45a during HR repair
results in hypomethylated GFP products as attested by
overall increases in GFP expression. We found no
evidence that G45a altered the efﬁciency or frequency of
HR in either G45a overexpressing cells or speciﬁc knock
Figure 2. Inﬂuence of G45a on HR and kinetics of G45a expression in
HO-1 cells. (A) Inﬂuence of ectopic G45a on GFP expression. HO-1
cells containing a single integrated copy of DR-GFP (see ‘Materials
and Methods’) were transfected with I-Sce plus or minus a plasmid
encoding G45a (both plasmids express constitutive levels using CMV
enhancer). GFP percent was determined 48h later concurrent with an
analysis of HR frequency using suitable primer pairs [see
Supplementary Figure S1 and (3) for details]. *P<0.03 between 0
and 0.25mg; P<0.0002 between 0 and 0.5mg (statistical signiﬁcance
determined using paired t-test and four experiments, see
Supplementary Figure S10). (B) Time course of G45a mRNA induction
after DSB. HeLa DR-GFP (HO-1) reporter cells were transfected by
I-SceI and RT-PCR performed to measure G45a mRNA levels (shaded
boxes) at various times post-transfection as described in the ‘Materials
and Methods’ section. Concurrently, GFP expression was monitored by
Figure 2. Continued
FACS analysis. The UV induction control to measure G45a mRNA
was performed 24h after UV exposure. (C) Time course of G45a
protein induction by DSB. HeLa DR-GFP cells were transfected with
I-SceI plasmid or with a control vector. Control cultures were
untransfected cells untreated (U) or etoposide treated for 18h (E).
Cell extracts were prepared at the indicated intervals (12–24–36h
after the I-SceI transfection) for transfected and at 36h for the
etoposide samples (untr., no I-SceI transfection). A representative
immunoblot with speciﬁc antibodies to G45a and a reference nuclear
protein (MCM7) in cell extracts from HeLa DRGFP cells treated (E)
or not (U) with etoposide or transfected with I-SceI or a control vector,
and analyzed at the times indicated. The lower panel shows the statis-
tical analysis of the G45a signals compared to a reference control
(MCM7). The data are derived from three independent experimental
determinations (P<0.0001 comparing 24–36h and 12h points)
(Supplementary Figure S10).
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sion due to constitutive G45a is not large (20–40% in-
creases), other data are consistent with this general
picture. Speciﬁcally, in G45a knock down cells, GFP
+
cells were reduced and the HR-L class (low expressors)
elevated to similar extents. Therefore, manipulating
G45a levels results in a mutually consistent outcome.
DNMT1 is inhibited when G45a is in excess and activated
when G45a is depleted, which results in hypomethylation
and hypermethylation, respectively.
Second, DNMT1 and G45a are interactive partners and
in vitro data show that the two bind directly. Thus, the
mechanism underlying G45a inhibitory action in vivo
appears to be at least partially due to its ability to bind
DNMT1. Moreover, since G45a binds the catalytic center
of DNMT1, G45a could block radial access to the DNA
target. We cannot rule out the prospect that G45 also
sequesters DNMT1 to reduce activity; however, this
seems unlikely for a couple of reasons. For example,
G45a binds hemimethylated DNA with a slightly higher
avidity compared to DNMT1 and in chromatin G45a
forms extremely stable complexes with genomic DNA
(M. T. Muller and B. Lee, manuscript in preparation).
In addition, G45a displays a signiﬁcantly higher afﬁnity
for hemi-methylated DNA over non-methylated or fully
methylated sites (50- to 100-fold). A recent report showed
that G45a binds to RNA and such complexes were par-
tially dissociated by adding hemi-methylated competitor
DNA (48). Moreover, these authors reported an RNase
insensitive complex of G45a present at the nuclear periph-
ery of nuclei (48). In our biochemical assays, G45a inhib-
ition was partially relieved by adding back excess
hemimethylated DNA substrate (Figure 4E). We
propose that G45a is retained at hemi-methylated sites
that appear somewhere along the DNA during (or soon
after) formation of the 30 overhang that attends HR
synapse. High afﬁnity binding of hemimethylated DNA
also suggests a means whereby G45a is likely to occupy
sites arising from de novo methylation by DNMT1.
Subsequently, G45a restricts DNMT1 activity by
blocking or occluding the opposing strand. Stable G45a
complexes could provide an effective barrier to long range
spreading of methylation during HR. Recent X-ray struc-
ture data with DNMT1 deﬁne the importance of the inter-
action between the target recognition domain (catalytic
center) and regions surrounding the BAH domains that
bind CpG. Interactions between these domains have been
reported to be critical in regulating de novo versus main-
tenance methylation by DNMT1 (41). Directed binding of
G45a at the catalytic center of DNMT1 would certainly
inhibit both mechanisms, as shown here (Figure 4). G45a
could limit DNMT1 and methylation spreading by a com-
binatorial mechanism of catalytic site binding and DNA
target afﬁnity. The process is of course dynamic and
involves precise timing of appearance of each participating
protein or subunit (see next point).
Third, based on ChIP data, G45a and DNMT1 are
associated with HR recombinant chromatin which places
endogenous reactants directly in contact with the 437-bp
region that undergoes gene conversion 30 of the break site.
When we compared endogenous and ectopically expressed
G45a, higher ChIP signals were seen when G45a was
overexpressed (Figure 3, using the same anti-G45a
antibody). DNMT1 signals were nearly identical in these
two situations; therefore, ectopically expressed G45a
enters the 437-bp segment of chromatin without attracting
additional DNMT1. G45a acts by preventing the existing
DNMT1 from gaining access to the DNA that is 30 of the
I-SceI site. We would further argue that G45a shields the
opposing strand to limit methyltransferase action by a
mechanism involving both hemimethylated DNA and
DNMT1 binding. Finally, it is worth noting that
DNMT1 and G45a interact by direct contact in vitro,
although we cannot rule out important bridging factors
that may operate to attract and retain DNMT1 at HR
sites (including hemimethylated DNA, a good substrate).
Fourth, alanine scanning mutations that alter the ability
of G45a to dimerize, adversely affect its ability to act as a
regulator of HR methylation (Figure 5). Structural studies
of Gadd45g by X-ray crystallography showed the
Figure 3. Chromatin immunoprecipitation during HR. ChIP assays
before and after HR repair. ChIP assays were performed as described
in the ‘Materials and Methods’ section in cells transfected with vector
DNA (‘none’), I-SceI plasmid (‘SceI’) or co-transfected with V-5-G45a
(N-terminal tag) plus I-SceI expression constructs at 48h after I-SceI
transfection. The precipitating antibodies used in each analysis are
shown. The 50 Rec primer ampliﬁes only HR recombinants. The
input Lanes 1–3 correspond to DNA inputs for none, SceI and
SceI+V5-G45a samples.
Nucleic Acids Research,2012, Vol.40, No. 6 2489importance of dimerization ability for this class of
proteins to interact with other binding partners in cell
cycle checkpoints following genotoxic events (8). The
alanine substitution mutants (Supplementary Figure S3)
displaying poor dimerization ability also bound DNMT1
poorly. As a consequence, GFP expression after HR was
reduced, presumably due to the fact that DNMT1 action
was elevated in the absence of the G45a over ride. A con-
sistent model emerges from these collective and diverse
observations. G45a appears to negatively modulate the
action of DNMT1 (and possibly other methylases that
contain the conserved catalytic domain) on hemi and
unmethylated DNA both in vitro and in a chromatin
setting. Since G45a is transiently expressed, its inﬂuence
is limited to situations where some kind of DNA damage
has occurred (HR or base excision repair); therefore, G45a
acts to modulate methylation under a strict set of physio-
logical conditions. Once the damage is repaired and the
cell cycle checkpoint reversed, G45a transcripts rapidly
turnover as expression is extinguished.
Mechanism of G45a action early in HR silencing
We compared kinetics of G45a gene transcription with the
appearance of the silenced population of GFP molecules.
G45a transcription was detected as early as 4-h post-I-
SceI, reached maximum levels by 8–12h and began to
decline around 24h. During this period of transcriptional
decline, G45a protein accumulates to highest levels and
the ﬁrst GFP positive cells begin to appear; however,
most of these ﬁrst GFP positive cells were HR-L (low
expressors; Supplementary Figure S4). The HR-L
fraction was elevated until 48h; thus, it appears that the
ﬁrst GFP+cells are silenced molecules. Since these HeLa
cell reporters have a population doubling time in excess of
20h, events that proceed during the ﬁrst 24h represent the
Figure 4. DNMT1 and G45a binding. (A) Immunoprecipitation
followed by western blotting show DNMT1 and G45a interact as
binding partners. DR-GFP HeLa cells were transfected with tagged
DNMT1 (C-terminal V5) and G45a (N-terminal Myc tag) genes.
Extracts were subjected to immunoprecipitation with Myc IgG and
western blot performed using a V5 IgG probe (upper panel) or a
Myc probe (lower panel). The position of each polypeptide is marked
along with the IgG light chain that is present in all samples (lower
blot). (B) Domain mapping. The DNMT1 protein was divided into
three domains corresponding to the N-terminus (residues 1-419),
central domain (412–1113) and C-terminus (1114–1616) containing
the conserved catalytic region of the methylase (39,41). The deletion
mutants are all V5 tagged and differences in expression levels were
Figure 4. Continued
normalized for each mutant and taken into account. HeLa cells were
transfected with Myc-G45a and DNMT1 mutants. At 48-h
post-transfection, extracts were immunoprecipitated with anti-V5 IgG
and recovery products probed on western blots with anti-Myc IgG
(upper blot). (C) Direct binding between DNMT1 domains and
G45a. GST tagged, puriﬁed domain segments of DNMT1 (residues
1–644, 645–1113 or 1100–1616) were incubated with puriﬁed G45a
and isolated by the GST tag. After extensive washing of the glutathione
afﬁnity resin, recovery products were run on an SDS–PAGE, which
was stained with Coomassie Blue (boxed upper panel). The same
samples were subjected to western blotting using an anti-G45a IgG
probe as described in the ‘Materials and Methods’ section. (D)
Effects of G45a binding on DNMT1 methylation activity in vitro.
DNMT1 methylase assays were carried out for 60min using 200ng
puriﬁed DNMT1 (from Baculovirus) and the indicated amount of
puriﬁed G45a (E. coli). The substrate was a 30-bp duplex oligo con-
taining a single CpG site that was either hemi- or unmethylated as
indicated. Radioactive Ado-Met incorporation was measured as
described in the ‘Materials and Methods’ section. The stoichiometric
(molar) ratios of G45a:DNMT1 were calculated to range from 2.5:1
(50ng G45a) to 7.5:1 (200ng G45a) using a predicted molecular mass
for the dimer form of G45a. (E) Time course of methylation and in-
hibition reversal. A time course of methylation of hemi-methylated
(HM) DNA substrate is shown plus or minus G45a (left panel). The
inﬂuence of excess HM DNA on inhibition is shown on the right panel
(under conditions that gave 50% inhibition by G45a with a ﬁxed
amount of HM DNA substrate).
2490 Nucleic Acids Research, 2012,Vol.40, No. 6original parental cell population undergoing HR (founder
cells). Founder cells represent HR and silencing processes
that are replete with hemi-methylated products and these
do not express well. That G45a protein appears about the
same time (or just prior to) HR-L founders, suggests an
early role for G45a in establishing or regulating the epi-
genetic alterations that attend HR (3).
Reports from several other labs indicate that G45a is an
important mediator of active demethylation (32,34,43,44)
and our ﬁndings do not contradict these results but
instead add new information regarding the mechanistic
underpinnings for the process. Although we cannot distin-
guish active versus passive demethylation, and considering
the rate of accumulation of HR-H cells, we suggest that
during repair, G45a maintains the hemimethylated state of
the repaired DNA by inhibiting DNMT1 locally (after
repair). Before disappearing, G45a may support active
demethylation coupled to transcription (M. Muller,
M. Gottesman and E. Avvedimento, manuscript in prep-
aration). Indeed, our data clearly demonstrate that G45a
displays high avidity binding at sites of hemimethylation
and this small protein has the unusual ability to inhibit
DNMT1 methylation activity as a result of targeted
binding to the catalytic domain. This places G45a at HR
regions undergoing methylation re-programming in chro-
matin (conﬁrmed by ChIP experiments). Catalytic inhib-
ition of the methylase then blocks localized DNMT1 from
acting on previously demethylated sites (arising by passive
mechanisms such as HR strand synthesis or active G45a
mediated events) (32,34,43,44). These data provide a
mechanistic overview of the importance of Gadd45
isoforms in setting DNA methylation programming in
cells and we would further argue that this family of
proteins should be excellent anti-cancer targets, given
the clinical importance of hypomethylation in therapy.
Future studies will be critical in establishing this potential.
SUPPLEMENTARY DATA
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Figure 5. Analysis of G45a alanine dimerization mutants. Alanine substitution mutations in G45a predicted to disrupt dimer formation
(Supplementary Figure S3) were used (8). The degree of self-association was assayed using cross tag immunoprecipitation (Myc and V5 tags) for
each mutation (see Supplementary Figure S5). The ability of each mutant to interact with DNMT1 in HeLa cells was assessed by co-transfecting each
V5 tagged DNMT1 with Myc-tagged G45a mutant and I-SceI, performing an immunoprecipitation with anti-V5 IgG followed by western probing
with anti-Myc IgG (upper blots). The graph below shows the collective digitized data. The shade bars represent the efﬁciency of DNMT1/G45a
binding. The band intensities of co-imunoprecipitated G45a mutants were quantiﬁed using the GeneTools program (SynGene, Cambridge, UK). The
amount of co-immunoprecipitated G45a was normalized to the amount of immunoprecipitated DNMT1 and plotted as a relative amount against
wild-type band intensity. The statistical data are based on three independent experiments. The white bars represent the efﬁciency of dimer formation
(from Supplementary Figure S5) and the stippled bars the percent total GFP expression.
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